Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
18.11
+0.53 (3.01%)
At close: Jul 21, 2025, 4:00 PM
18.30
+0.19 (1.05%)
Pre-market: Jul 22, 2025, 4:16 AM EDT
Omada Health Market Cap
Omada Health has a market cap or net worth of $1.03 billion as of July 22, 2025.
Market Cap
1.03B
Enterprise Value
1.00B
1-Year Change
n/a
Ranking
Category
Stock Price
18.11
Market Cap Chart
Since the IPO on June 6, 2025, Omada Health's market cap has decreased from $1.06B to $1.03B, a decrease of -2.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 21, 2025 | 1.03B | 3.01% |
Jul 18, 2025 | 1.00B | -0.62% |
Jul 17, 2025 | 1.01B | -4.38% |
Jul 16, 2025 | 1.05B | 2.83% |
Jul 15, 2025 | 1.02B | 2.51% |
Jul 14, 2025 | 999.11M | -0.68% |
Jul 11, 2025 | 1.01B | -1.40% |
Jul 10, 2025 | 1.02B | 6.35% |
Jul 9, 2025 | 959.26M | -3.60% |
Jul 8, 2025 | 995.12M | -6.37% |
Jul 7, 2025 | 1.06B | 0.21% |
Jul 3, 2025 | 1.06B | 2.93% |
Jul 2, 2025 | 1.03B | -0.82% |
Jul 1, 2025 | 1.04B | -0.27% |
Jun 30, 2025 | 1.04B | 3.92% |
Jun 27, 2025 | 1.00B | -1.45% |
Jun 26, 2025 | 1.02B | 1.88% |
Jun 25, 2025 | 998.54M | 11.79% |
Jun 24, 2025 | 893.22M | 5.66% |
Jun 23, 2025 | 845.40M | -2.30% |
Jun 20, 2025 | 865.33M | -1.87% |
Jun 18, 2025 | 881.84M | 2.18% |
Jun 17, 2025 | 863.05M | -3.68% |
Jun 16, 2025 | 896.07M | -7.95% |
Jun 13, 2025 | 973.49M | -0.47% |
Jun 12, 2025 | 978.05M | 11.56% |
Jun 11, 2025 | 876.71M | -15.38% |
Jun 10, 2025 | 1.04B | -19.47% |
Jun 9, 2025 | 1.29B | 21.48% |
Jun 6, 2025 | 1.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 684.24B |
Johnson & Johnson | 395.46B |
AbbVie | 326.52B |
Novo Nordisk | 286.26B |
UnitedHealth Group | 255.94B |
Novartis AG | 222.44B |
Abbott Laboratories | 216.47B |
AstraZeneca | 214.29B |